© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Truvada

POZ March 2019 cover U=U Undetectable = Untransmitable
How Well Do U=U and PrEP Work? The CDC Updates Its Answers
Truvada (tenofovir disoproxil fumarate + emtricitabine) 101
Chart of Approved and Experimental HIV Medications

For Pregnant Women With HIV, Dolutegravir-Based Regimens Are Apparently Safest

Researchers compared regimens prescribed to pregnant women in their second trimester.

HIV Prevention PrEP to Be Readily Available in England (Finally)

The country’s National Health Service will pay for the drug as part of its goal to end HIV transmission by 2030.

In Developing Nations, PrEP Use Lags in Sex Workers, Gay Men, Trans Women

The U.S. PEPFAR program analyzed PrEP scale-up patterns and found that growth was greater among cisgender heterosexuals.

CROI 2020: Coronavirus Won’t (Entirely) Stop Conference

Attendees will hear news about the second probable HIV cure, long-acting injectable meds and COVID-19.

PrEP Use Tied to Some Drug Resistance in Those Who Contract HIV

In a recent small study, resistance was limited to the emtricitabine component of Truvada and did not seem a major cause for concern.
Screenshot of a misleading ad that recently appeared on Facebook

They’re Still Here! Scary HIV Ads on Facebook Won’t Go Away

Misleading ads about Truvada as PrEP continue to impede HIV prevention.

Even With New, Bone-Friendly HIV Regimens, More Bone Research Is Needed

This is especially the case for people globally who don’t have access to such newer regimens.
Misleading Facebook ads

About Those Scary HIV Ads on Facebook…

Activists want the tech giant to take down similar ads with inaccurate claims about PrEP and HIV prevention.

PrEP Is Safe for Pregnant Women, but More Research Is Needed

Despite unanswered questions about PrEP’s safety and efficacy for pregnant women, they shouldn’t be denied Truvada for HIV prevention.
A woman holds the dapivirine vaginal ring

Trial Will Assess HIV-Preventing Vaginal Ring and PrEP in Pregnant Women

The safety trial will enroll pregnant women in several sub-Saharan African nations.

Gilead Loses Latest Battle Over PrEP Patents, but the Fight Goes On

Who owns the rights to PrEP? The U.S. government or the pharma giant?

PrEP May Be Available Without a Doc’s Prescription in Two More States

They would follow the lead of California, which allows pharmacies to dispense a 30-day supply of the HIV prevention pill without a script.
Emily Goodrow and Peter Staley

Drug Company Antitrust Trial Gets 2022 Court Date

Advocates claim Gilead and others unfairly limited competition for HIV combination pills.
Descoy and Truvada

Men Who Turn Down PrEP Often Don’t Think They’re at Risk for HIV

Canadian researchers analyzed the reasons why people declined a nurse’s offer of PrEP.

Why HIV Rates Dropped 71% Among Gay and Bi Men in the U.K.

It’s not just because of PrEP, which isn’t even easily available in England.
Descovy and Truvada

Truvada Should Remain First Choice for PrEP, Experts Argue

Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.
Advertisement
Treatment News
Blog: Undetectable = Untransmittable